The researchers took a close look at the virus's entire replication cycle. 

© Molekulare und Medizinische Virologie

Virology

Why the Hepatitis E Virus Cannot Infect Mice

Mouse liver cells are not a suitable host for hepatitis E viruses. The Virology department in Bochum has discovered why.

Many viruses can infect both humans and animals, including hepatitis E virus. This virus is often transmitted to humans via contaminated meat products, such as when ingesting raw or undercooked pork or wild game. However, while mice have been believed to be resistant to infection, the underlying reason for this was unclear. The team of researchers from the Ruhr University Bochum Department of Molecular and Medical Virology, Germany, has now investigated the viral replication cycle in detailand discovered that the species barrier in mice is defined at the point of viral entry into the cell. First author Dr. Nicola Frericks and her team of researchers report their findings in the journal Emerging Microbes & Infections from July 27, 2026.

Genetic material is not unpacked

It has long been known that the hepatitis E virus cannot establish an infection in mice, but the reasons were unknown. The virology research team in Bochum therefore systematically examined the replication cycle of the virus in liver cell cultures of mice. “We observed that most processes of viral infection also function in mouse cells,” reports Frericks. Viral particles attached to murine hepatocytes andnew virus particles could also be formed and released from the host cell if viral entry was bypassed. “But functional cell entry is blocked,” the scientist continues. “Even when our findings indicate that the virus particles are imported, the viral genetic material is likely not unpacked in the mouse cells.”

This is important for a variety of reasons: For one, it improves our understanding of the host range of this zoonotic virus and help assess the risk of transmission to other animal species. Secondly, it could pave the way for establishing a mouse model to study the disease. “This would be immensely helpful in testing therapeutic approaches,” says Frericks. “There is still no specific, effective treatment for hepatitis E.”

Hepatitis E

The hepatitis E virus (HEV) is one of the main causes of acute viral hepatitis. Up to about 70,000 people die every year from the disease. After the first documented epidemic outbreak from 1955 to 1956, it took approximately 50 years before researchers began to intensively study the topic. Acute infections normally cure themselves in patients with intact immune systems, but HEV can become chronic in individuals with a reduced or suppressed immune system, as well as organ transplant recipients or persons infected with HIV. The virus is also particularly dangerous to pregnant women. There is no vaccination or specific active antiviral available in Europe.

 

Funding

The work was funded by the Federal Ministry of Research, Technology and Space, the German Research Foundation, the German Center for Infection Research, and Carl von Ossietzky University of Oldenburg.

 

Original publication

Nicola Frericks et al.: Viral Entry Defines the Hepatitis E Virus Species Barrier in Murine Hepatocytes, in: Emerging Microbes & Infections, 2026, DOI: 10.1080/22221751.2026.2706321

 

Press contact

Dr. Nicola Frericks
Department of Molecular and Medical Virology
Ruhr University Bochum
Germany
Tel: +49 234 32 26465
Email: nicola.frericks@ruhr-uni-bochum.de

Published

Wednesday
29 July 2026
11:25 am

By

Meike Drießen (md)

Translated by

Allround Fremdsprachen GmbH von der Lühe

Share